Noboru Imai

8PUBLICATIONS
14CO-AUTHORS
Molecular imaging (incl. electron microscopy and neutron diffraction)Neurology and neuromuscular diseasesTraditional Chinese medicine and treatmentsGene and molecular therapyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 01, 2024
Differences in Static and Dynamic Resting-State Functional Connectivity between Migraineurs with and without Photophobia, without Phonophobia or Osmophobia.

Noboru Imai, Asami Moriya, Eiji Kitamura

|Oct 26, 2024
Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review.

Eiji Kitamura, Noboru Imai

|Jun 27, 2024
Preliminary External Validation Results of the Artificial Intelligence-Based Headache Diagnostic Model: A Multicenter Prospective Observational Study.

Mariko Okada, Masahito Katsuki, Tomokazu Shimazu

|May 31, 2023
Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study.

Shigekazu Kitamura, Noboru Imai, Yuka Tanji

|Dec 29, 2022
A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at home.

Koichi Hirata, Takao Takeshima, Noboru Imai

|Jul 29, 2021
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim

Pageof 2

Frequent Collaborators

2 joint publications

Nobuyuki Koga

2 joint publications

Takao Takeshima

1 joint publications

Miho Iigaya

1 joint publications

Fumihiko Sakai